Tirzepatide niacinamide is a compounded GLP-1/GIP formula with vitamin B3 added. Learn why pharmacies mix them, what the evidence says, and key risks.
Tirzepatide with niacinamide is a compounded GLP-1/GIP injection in which a compounding pharmacy adds vitamin B3 (niacinamide) to the same vial as the tirzepatide. Niacinamide is not a weight-loss drug and does not change how tirzepatide works — it is added as a supportive vitamin, usually marketed as a way to improve tolerability, energy, or skin. Tirzepatide is FDA-approved as Mounjaro and Zepbound, but compounded formulas that contain additives like niacinamide are not FDA-approved.
Knowing what the additive actually does — and does not do — helps you ask better questions before you start or switch treatment.
What Is Tirzepatide With Niacinamide?
Tirzepatide is a dual GIP and GLP-1 receptor agonist prescribed for type 2 diabetes and chronic weight management. Compounded tirzepatide is a pharmacy-made copy that is legal only in limited circumstances, such as when a patient cannot tolerate an FDA-approved version or needs a strength that is not commercially available.
Some compounders add a vitamin to that copy. When the additive is niacinamide — the amide form of vitamin B3 — the product is often labeled "tirzepatide / niacinamide." Other common pairings include vitamin B12, L-carnitine, and glycine.
Key points about the combination:
- Niacinamide is water-soluble and already present in the human body; it plays a role in NAD+ production and skin barrier function.
- It is not an appetite suppressant, a metabolism booster, or a fat burner.
- The tirzepatide dose is what drives weight loss and blood sugar effects, not the vitamin.
- Compounded tirzepatide has not been reviewed by the FDA for safety, effectiveness, or manufacturing quality.
Why Compounding Pharmacies Add Niacinamide
There is no clinical trial showing that niacinamide improves tirzepatide outcomes. The rationale is mostly practical and commercial: added vitamins let a pharmacy offer a differentiated formula and market "extra support" for energy, skin, or tolerability.
| Additive | What it is | Common marketing claim | Evidence for added benefit |
|---|---|---|---|
| Niacinamide (B3) | Water-soluble vitamin | Skin support, less flushing, energy | None in combination with tirzepatide |
| Vitamin B12 | B vitamin for nerves and blood cells | Energy, fewer GI side effects | Helps only if you are deficient |
| L-carnitine | Compound involved in fat transport | Fat loss, muscle preservation | No trials with tirzepatide |
| Glycine | Amino acid | Injection comfort | None |
Makers of lipotropic injections use very similar claims. Search interest in lipo-c vs tirzepatide usually comes down to whether someone wants a vitamin-based "fat burner" or an FDA-approved GLP-1/GIP drug — and only the latter has large randomized trial data behind it.
The same logic applies to tirzepatide with l-carnitine: an added nutrient with no proven effect on weight loss.
Does Niacinamide Boost Weight Loss? What the Evidence Shows
No. There is no published human data showing that adding niacinamide to tirzepatide increases weight loss, improves blood sugar, or reduces nausea compared with tirzepatide alone.
Niacinamide does have real, well-documented uses. Topical niacinamide is studied for acne, redness, and skin barrier repair, and oral niacinamide is used in some dermatology settings. Those uses are unrelated to injectable weight management. Niacinamide appears in skincare products ranging from serums to an aplb glutathione niacinamide facial cream, but topical evidence does not transfer to a subcutaneous injection.
Niacinamide vs. Niacin: Why the Distinction Matters
Niacinamide and niacin (nicotinic acid) are both vitamin B3, but they behave very differently in the body. High-dose niacin causes flushing and is used to change cholesterol levels; niacinamide does not flush and is not used for cholesterol.
This matters because high-dose niacinamide is not risk-free. Daily doses above roughly 1,500 mg have been linked to nausea, dizziness, and liver enzyme changes in some patients. The amount in a compounded tirzepatide vial is typically small, but the exact quantity is often not printed in a way patients can easily verify.
Side Effects and Safety Considerations
Tirzepatide carries a boxed warning for thyroid C-cell tumors and is not for people with a personal or family history of medullary thyroid cancer or MEN2. Common side effects include nausea, vomiting, diarrhea, constipation, and injection site reactions.
Adding niacinamide may bring its own issues:
- Redness, itching, or soreness at the injection site
- Nausea or dizziness if the vitamin dose is high
- Allergic reaction in people sensitive to B3
- Unknown long-term effects of injecting a vitamin normally taken by mouth
Injectable niacinamide is not an approved route of administration for this vitamin, so any benefit remains theoretical.
Compounded Tirzepatide vs. Other Options
The FDA removed tirzepatide from its drug shortage list in late 2024 and directed compounding pharmacies to stop mass-producing copies in early 2025, though limited 503A exceptions and ongoing litigation have kept some products on the market. That makes the additive question less important than the bigger ones: is the product legally made, tested, and prescribed by a licensed clinician?
Newer amylin-based drugs are also moving through trials, and interest in cagrilintide vs tirzepatide reflects curiosity about what may come next for weight management. A common question is can you take semaglutide and tirzepatide at the same time — the answer is no. Stacking two GLP-1 medications is not recommended and raises the risk of severe gastrointestinal side effects.
Questions to Ask Before You Inject
- Which pharmacy made this vial, and is it licensed in my state?
- How much niacinamide is in each dose, and why was it added?
- Can I get the same strength without the additive?
- What is the plan if I develop side effects?
- Would an FDA-approved product such as Zepbound be an option for me?
Tirzepatide plus niacinamide is not a proven combination, and no added vitamin can replace medical supervision. Talk with a licensed healthcare professional — ideally one who prescribes GLP-1 medications regularly — before starting, stopping, or switching any weight-management treatment.
Frequently Asked Questions
What is tirzepatide with niacinamide?
It is a compounded tirzepatide injection with vitamin B3 (niacinamide) added by the pharmacy. Niacinamide is included as a supportive vitamin rather than an active weight-loss ingredient, and this combination has not been evaluated or approved by the FDA.
Does niacinamide in tirzepatide help with weight loss?
No. There is no clinical evidence that niacinamide adds weight loss, blood sugar control, or tolerability benefits to tirzepatide. Any weight loss from the product comes from the tirzepatide itself, which is the only active ingredient with proven results.
Is compounded tirzepatide with niacinamide still available in the US?
Availability has tightened since the FDA ended the tirzepatide shortage in late 2024 and told compounders to stop mass production in early 2025. Some 503A pharmacies still fill limited prescriptions, but the legal landscape shifts often, so confirm current status with your pharmacist and prescriber.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.